Robert Landry
Director of Finance/CFO bij CHECKMATE PHARMACEUTICALS, INC.
Vermogen: 23 M $ op 31-03-2024
Profiel
Robert E. Landry is Chief Financial Officer & Executive VP-Finance bij Regeneron Pharmaceuticals, Inc. Daarvoor was hij Treasurer & Senior Vice President bij Pfizer Inc. Director-Pharmaceutical Marketing & Sales bij Wyeth Australia Pty Ltd. Chief Financial Officer van Wyeth Nieuw-Zeeland en Treasurer & Principal Corporate Officer bij Wyeth Corp. (die allemaal dochterondernemingen zijn van Pfizer Inc.). De heer Landry behaalde een bachelorgraad aan de Universiteit van Notre Dame.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-02-2024 | 23 963 ( 0.02% ) | 23 M $ | 31-03-2024 |
Actieve functies van Robert Landry
| Bedrijven | Functie | Begin |
|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Director of Finance/CFO | 31-05-2022 |
| DECIBEL THERAPEUTICS, INC. | Director of Finance/CFO | 22-09-2023 |
Eerdere bekende functies van Robert Landry
| Bedrijven | Functie | Einde |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Director of Finance/CFO | 05-02-2024 |
| PFIZER, INC. | Corporate Officer/Principal | 01-10-2012 |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Treasurer | 01-10-2009 |
| Wyeth Australia Pty Ltd. | Director of Finance/CFO | 01-01-2006 |
| Wyeth New Zealand | Director of Finance/CFO | 01-01-2006 |
Opleiding van Robert Landry
| University of Notre Dame | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| DECIBEL THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
| Wyeth Australia Pty Ltd. | |
| Wyeth New Zealand | |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
